Share

January 15, 2013; 80 (3) Views & Reviews

A quantitative systematic review of domain-specific cognitive impairment in lacunar stroke

Jodi D. Edwards, Claudia Jacova, Amir A. Sepehry, Brandy Pratt, Oscar R. Benavente
First published January 14, 2013, DOI: https://doi.org/10.1212/WNL.0b013e31827deb85
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
689

Share

Article Information

vol. 80 no. 3 315-322
DOI: 
https://doi.org/10.1212/WNL.0b013e31827deb85
PubMed: 
23319476
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received May 11, 2012
  • Accepted August 10, 2012
  • First Published January 14, 2013.
Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Jodi D. Edwards, MA,
    2. Claudia Jacova, PhD,
    3. Amir A. Sepehry, MSc,
    4. Brandy Pratt, BKin and
    5. Oscar R. Benavente, MD, FRCP(C)
  1. Jodi D. Edwards, MA,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Canadian Institutes of Health Research, Doctoral Research Award, 3 years

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Claudia Jacova, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. Jacova, C., Hsiung, GYR, McGrenere, J, Lee, H. Cognitive Testing on Computer (C-TOC). Invention disclosure and Assignment - Life Sciences (UBC University-Industry Liaison Office file # 11-123). Submitted March 2011.

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. BC Ministry of Health PharmaCare Services Division, Alzheimer Drug Therapy Initiative - Clinical Meaningfulness in Alzheimer Disease Treatment (CLIMAT) Study, Principal Investigator

    Research Support, Academic Entities:

    1. Canadian Institutes of Health Research, Frontotemporal Lobar Degeneration with Ubiquitinated Inclusions: Genetic, clinical, pathological and biomarker studies, Co-Investigator

    Research Support, Foundations and Societies:

    1. Canadian Stroke Network / Heart & Stroke Foundation, Role of exercise on cognition and function in seniors with Vascular Cognitive Impairment, Co-InvestigatorAlzheimer Society of Canada, A Randomized Controlled Trial of Group Music Therapy in the Care of Patients with Mild to Moderate Alzheimer Disease, Co-Investigator

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Amir A. Sepehry, MSc,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Canadian Psychological Association division of Psychopharmacology, Editor for Psynapse.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. Canadian Institutes of Health Research: Doctoral Award

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Brandy Pratt, BKin and
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Oscar R. Benavente, MD, FRCP(C)
    6. Scientific Advisory Boards:

    1. Honorarium for lectures from Sanofi-BMS, Otsuka, BayerConsultan for OtsukaAdvisory Board from Sanofi

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Honorarium from Sanofi, Otsuka, Bayer

    Editorial Boards:

    1. Advisory Board member for Sanofi

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Consultant for Otsuka

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Funded by NIH

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the School of Population and Public Health (J.D.E.), Division of Neurology (C.J., B.P., O.R.B.), and College of Interdisciplinary Studies Program in Neuroscience (A.A.S., O.R.B.), University of British Columbia, Vancouver, Canada.
  1. Correspondence to Dr. Benavente: oscar.benavente{at}ubc.ca
View Full Text

Article usage

Article usage: January 2013 to July 2020

AbstractFullPdfSource
Jan 201310572254Highwire
Feb 20131421018Highwire
Mar 20131041210Highwire
Apr 201310747Highwire
May 201368812Highwire
Jun 20137258Highwire
Jul 20137067Highwire
Aug 20135624Highwire
Sep 201362610Highwire
Oct 201310327Highwire
Nov 20137568Highwire
Dec 201363413Highwire
Jan 20147247Highwire
Jan 2014099pmc
Feb 20145623Highwire
Mar 20149843Highwire
Apr 20147334Highwire
May 20145042Highwire
Jun 20143602Highwire
Jul 20144724Highwire
Aug 20144324Highwire
Sep 20144033Highwire
Oct 20143411Highwire
Nov 20143212Highwire
Dec 20144712Highwire
Jan 20155312Highwire
Jan 201501711pmc
Feb 20157003Highwire
Feb 201502112pmc
Mar 20158315Highwire
Mar 20150106pmc
Apr 20155121Highwire
Apr 201501410pmc
May 20153501Highwire
May 20150149pmc
Jun 20154322Highwire
Jun 20150239pmc
Jul 20152821Highwire
Jul 201501615pmc
Aug 20153723Highwire
Aug 2015087pmc
Sep 20152900Highwire
Sep 20150189pmc
Oct 20152800Highwire
Oct 20150157pmc
Nov 20154822Highwire
Nov 201502011pmc
Dec 20154500Highwire
Dec 20150159pmc
Jan 20164110Highwire
Jan 20160127pmc
Feb 20163711Highwire
Feb 2016082pmc
Mar 20163700Highwire
Mar 20160167pmc
Apr 20164801Highwire
Apr 201601510pmc
May 20163201Highwire
May 20160127pmc
Jun 20163200Highwire
Jun 201602714pmc
Jul 20162112Highwire
Jul 2016084pmc
Aug 20164802Highwire
Aug 20160156pmc
Sep 20162600Highwire
Sep 20160165pmc
Oct 20164510Highwire
Oct 201601811pmc
Nov 20164300Highwire
Nov 20160168pmc
Dec 20164201Highwire
Dec 20160215pmc
Jan 20173610Highwire
Jan 201701410pmc
Feb 20171811Highwire
Feb 201702213pmc
Mar 20173211Highwire
Mar 20170189pmc
Apr 20174600Highwire
Apr 201761210pmc
May 20173922Highwire
May 201771821pmc
Jun 20172500Highwire
Jun 2017479pmc
Jul 20172900Highwire
Jul 201751318pmc
Aug 20172711Highwire
Aug 201741719pmc
Sep 20172411Highwire
Sep 2017112223pmc
Oct 20174301Highwire
Oct 201781516pmc
Nov 20172310Highwire
Nov 201751112pmc
Dec 20172512Highwire
Jan 20183201Highwire
Feb 20181700Highwire
Mar 20183025Highwire
Apr 20182921Highwire
Apr 201861919pmc
May 20181400Highwire
Jun 20185102Highwire
Jun 201851616pmc
Jul 20181711Highwire
Aug 20182001Highwire
Aug 201862829pmc
Sep 20181200Highwire
Oct 20183901Highwire
Nov 20181600Highwire
Dec 20181600Highwire
Jan 20193101Highwire
Feb 20194102Highwire
Mar 20194100Highwire
Apr 20192110Highwire
May 20192621Highwire
Jun 20194130Highwire
Jul 20193401Highwire
Aug 20192221Highwire
Sep 20192600Highwire
Oct 20195110Highwire
Nov 20194701Highwire
Dec 20192801Highwire
Jan 20204400Highwire
Feb 20203521Highwire
Mar 20204710Highwire
Apr 20203600Highwire
May 20202931Highwire
Jun 20202600Highwire
Jul 20202701Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me